Dr. Robyn Kerr

Robyn Kerr is a South African human geneticist affiliated with the University of the Witwatersrand, where she has contributed extensively to research on inherited disorders in African populations. Her work is closely linked to the Division of Human Genetics and to continental initiatives advancing genomic science and ethical data governance. She is recognized for sustained scholarship on oculocutaneous albinism and for strengthening genetics services in resource-constrained settings.

Her research centers on the clinical, molecular, and psychosocial dimensions of oculocutaneous albinism in southern Africa, including mutation profiling, epidemiology, and community impact. She has clarified prevalent OCA variants in African populations and highlighted the burden of skin cancer and stigma. Complementary studies address rare Mendelian disorders, such as Cornelia de Lange syndrome, and propose feasible next-generation sequencing strategies for public healthcare systems.

Kerr has also contributed to genomic medicine policy and practice through involvement in African data governance frameworks, supporting responsible access to biospecimens and broad consent models. Additional work in cardiovascular genetics and microbiome research reflects a wider commitment to precision medicine in Africa. Her scholarship integrates laboratory science, clinical care, and community engagement to improve equitable access to genetic services.